Vaccinex Inc

+0.01 (+1.71%)
5:58:12 PM EDT: $0.61 +0.02 (+2.54%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Vaccinex Inc Stock, NASDAQ:VCNX

1895 Mount Hope Avenue, Rochester, New York 14620
United States of America
Phone: +1.585.271.2700
Number of Employees: 39


Vaccinex, Inc. operates as a clinical-stage biotechnology company. It engages in the development of targeted bio therapeutics to treat serious diseases and conditions with unmet medical needs, including cancer, neurodegenerative diseases, and autoimmune disorders. The firm focuses on the development of Pepinemab for the treatment of non-small cell lung cancer, or NSCLC, osteosarcoma, melanoma, and Huntingtonâ??s disease. Its product pipeline includes the SEMA4D antibody platform and ActivMAb antibody discovery platform. The company was founded by Maurice Zauderer and Deepak Sahasrabudhe in 1997 and is headquartered in Rochester, NY.